Riociguat: new therapeutic approach for cardiac amyloidosis?

被引：0
|
作者：
Duca, F. [1 ]
Aschauer, S. [1 ]
Kammerlander, A. [1 ]
Zotter-Tufaro, C. [1 ]
Schreiber, C. [1 ]
Koell, B. [1 ]
Mascherbauer, J. [1 ]
Bonderman, D. [1 ]
机构：
[1] Med Univ Wien, Kardiol, Vienna, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2015年 / 127卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
XVII-5
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Riociguat: new therapeutic approach for cardiac amyloidosis?
    Duca, F.
    Aschauer, S.
    Kammerlander, A.
    Zotter-Tufaro, C.
    Schreiber, C.
    Koell, B.
    Mascherbauer, J.
    Bonderman, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (SUPPL 1) : S54 - S54
  • [2] Riociguat - new therapeutic approach in the management of cardiac amyloidosis
    Duca, F.
    Zotter-Tufaro, C.
    Kammerlander, A.
    Aschauer, S.
    Boerries, B.
    Agis, H.
    Mascherbauer, J.
    Bonderman, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S325 - S326
  • [3] Riociguat - New therapeutic approach in the management of cardiac amyloidosis
    Duca, F.
    Zotter-Tufaro, C.
    Kammerlander, A.
    Aschauer, S.
    Boerries, B.
    Agis, H.
    Mascherbauer, J.
    Bonderman, D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 530 - 530
  • [4] Riociguat - new therapeutic option in the management of cardiac amyloidosis
    Duca, F. Franz
    Zotter-Tufaro, C.
    Kammerlander, A.
    Aschauer, S.
    Boerries, B.
    Agis, H.
    Mascherbauer, J.
    Bonderman, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 155 - 155
  • [5] NEW THERAPEUTIC PERSPECTIVES IN CARDIAC AMYLOIDOSIS
    Giovannetti, Alessandro
    Accietto, Antonella
    Caponetti, Angelo Giuseppe
    Saturi, Giulia
    Ponziani, Alberto
    Massa, Paolo
    Sguazzotti, Maurizio
    Gagliardi, Christian
    Galie, Nazzareno
    Biagini, Elena
    Longhi, Simone
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [6] Vutrisiran: A new therapeutic option for cardiac transthyretin amyloidosis
    Panichella, Giorgia
    Aimo, Alberto
    GIORNALE ITALIANO DI CARDIOLOGIA, 2024, 25 (12) : 864 - 867
  • [7] Time for new imaging and therapeutic approaches in cardiac amyloidosis
    Slart, Riemer H. J. A.
    Glaudemans, Andor W. J. M.
    Noordzij, Walter
    Bijzet, Johan
    Hazenberg, Bouke P. C.
    Nienhuis, Hans L. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (07) : 1402 - 1406
  • [8] Time for new imaging and therapeutic approaches in cardiac amyloidosis
    Riemer H. J. A. Slart
    Andor W. J. M. Glaudemans
    Walter Noordzij
    Johan Bijzet
    Bouke P. C. Hazenberg
    Hans L. A. Nienhuis
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1402 - 1406
  • [9] Riociguat in transthyretin cardiac amyloidosis - experiences from a prospective heart failure registry
    Duca, F. Franz
    Zotter-Tufaro, C.
    Binder, C.
    Kammerlander, A. A.
    Boerries, B.
    Agis, H.
    Kain, R.
    Mascherbauer, J.
    Bonderman, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 461 - 462
  • [10] Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis
    Griffin, Jan M.
    Rosenblum, Hannah
    Maurer, Mathew S.
    CIRCULATION RESEARCH, 2021, 128 (10) : 1554 - 1575
12345